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Introduction
Abdominal aortic aneurysm surgery with supra-renal
clamping is associated with potential development of
renal insufficiency. Ischemia and reperfusion (I-R) pro-
duced during the procedure induces endothelial dysfunc-
tion with a decrease in tetrahydrobiopterin (BH4), a
cofactor used in nitric oxide synthesis.
Objectives
To assess whether BH4 administration could prevent the
injury to the renal microcirculation caused by supra-
renal aortic clamping with I-R.
Methods
Nineteen adult sheep were anesthetized, mechanically ven-
tilated and invasively monitored. Renal blood-flow was
measured continuously through a left lumbotomy using a
peri-vascular flow probe (Transonic, USA) and an aortic
clamp was positioned above the renal arteries. After surgi-
cal preparation and stabilization, animals were randomized
into 3 groups (SHAM=5, I-R=7, I-R+BH4=7). SHAM ani-
mals underwent surgical preparation but no aortic clamp-
ing was performed. The I-R groups were exposed to
1 hour of aortic ischemia. The I-R+BH4 group received
20 mg/kg of BH4 before aortic clamping. Animals were
followed for a maximum of 6 hours after reperfusion.
Renal microcirculation was evaluated at baseline, and 1, 4
and 6 hours after reperfusion using Sidestream Dark Field
video-microscopy (Microvision Medical, Netherlands). We
calculated perfused small vessel density (PVD), proportion
of perfused small vessels (PPV) and heterogeneity of PPV
(PPV-HI). Data were analyzed using the generalized
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Table 1 Microcirculatory parameters in the 3 groups
Group Baseline 1h 4h 6h P Group*Time
PVD (vessels/mm) SHAM 2.6 (2.5-2.7) 2.7 (2.3-2.9) 2.4 (2.2-2.7) 2.3 (2.3-2.5) c P<0.05
I-R 3.2 (2.9-3.7) 2.0 (1.5-2.8) c 2.1 (1.7-2.7) c 1.6 (1.3-2.3) a, c
I-R+BH4 3.2 (2.7-3.4) 3.0 (2.6-3.3) b 2.5 (2.0-3.1) b, c 3.1 (2.4-3.8) b
PPV (%) SHAM 93.7 (93.3-94.7) 87.6 (84.2-90.6) c 83.0 (80.3-90.2) c 85.5 (82.0-90.4) c P=0.269
I-R 97.3 (96.0-97.9) 80.1 (73.5-90.2) c 82.7 (68.5-88.7) c 79.8 (74.9-84.6) c
I-R+BH4 97.8 (96.8-98.3) 92.3 (89.8-93.8) b, c 85.9 (80.9-91.5) c 89.3 (86.0-99.4) c
PPV-HI (%) SHAM 11.9 (8.9-13.2) 18.4 (16.5-22.8) c 14.2 (11.0-15.1) 14.4 (11.3-39.0) P<0.05
I-R 9.6 (5.5-11.0) 43.0 (22.2-84.0) a, c 41.8 (28.2-97.7) a, c 47.3 (11.1-76.3) c
I-R+BH4 9.3 (7.3-12.5) 24.7 (17.1-32.8) c 42.8 (29.1-56.2) c 25.4 (2.9-40.5) c
[values are presented as median with P25-75]
a: significant difference between groups I-R and SHAM
b: significant difference between groups I-R and BH4+I-R
c: significant difference with the baseline.
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estimating equation (GEE) and p-values less than 5% were
considered statistically significant. Results are presented as
median [IQRs].
Results
The systemic hemodynamics variables were preserved in
all 3 groups. BH4 was associated with improved renal
function, as evaluated by creatinine after 6 hours of reper-
fusion in the I-R+BH4 group (14 mg/L [13-17]) compared
to the I-R group (16 mg/L [16-22]) (P=0.072).
Conclusions
In a sheep model of renal I-R, BH4 pre-treatment can
prevent microvascular injury and dysfunction. Clinical
trials are warranted to evaluate the administration of
BH4 to prevent I-R-induced kidney injury.
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